͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| | | | Are you a Cancer Research UK-funded researcher or PhD student? We need to learn about the outcomes of your work. The information you share is key to evaluating our shared progress and helping us communicate it to our supporters and partners.
Our research outcomes submission window is open now until Thursday 13 March. Read our submission tips to help with your submission. |
| | |
| | |
|
|
|
|
Funding & Research Opportunities |
| Get in touch with our office for confidential advice on eligibility, remit and funding options prior to applying. |
|
| | | | | | | | | | | | | | | | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
|
| | |
|
|
Can shopping data help diagnose cancer earlier? |
| Using big data to uncover early signal of cancer means thinking outside the box – and that’s exactly what researchers Jame Flanagan and Sima Toopchiani from Imperial College London did.
The Cancer Loyalty Card Study (CLOCS) collected six years of loyalty card data from two major retailers to track women's purchases before an ovarian cancer diagnosis. The findings revealed that many women bought products like pain and indigestion medication.
CLOCS-2 now aims to expand its focus on other cancer types, helping improve early diagnosis and impact patient outcomes.
|
| | |
|
|
|
| | | | | Leadership is a mindset, not a job role. That’s something the group of post-docs taking part in our Bridge to Academic Leadership programme have been discovering.
The programme supports postdocs to transition to independent academic positions and in a recent session, they examined their own leadership styles and learned techniques to align their values with running a team. This session also emphasised the importance of continually refreshing your leadership training because as your career progresses, so does your role as a leader.
You can take advantage of our leadership coaching opportunities and touch up your skills. | | |
| | | | | | | We need to urgently address the declining number of clinical researchers. They’re a vital part of our workforce, driving new and better ways to beat cancer, from discoveries in the lab all the way through to the clinic.
We’re working with partners across the medical research sector to implement recommendations to ensure that we continue to deliver world-class clinical research in the UK.
This report makes important recommendations on how we can improve the training and career opportunities available to clinical researchers, building a sustainable clinical research workforce for the future. | | |
|
|---|
|
|
|
|
| | | | | The focus this World Cancer Day is on equitable access and high-quality care for all, and we’re highlighting the need to reduce cancer inequalities through research. We spoke to researchers about what will be key to tackling this.
A common theme across answers was the need to address limited understanding of the causes of inequalities and the interplay between biological factors with other socio-economic and behavioural factors.
You can watch back the video, shot in 2023, of researchers Sigourney Bonner, Kay-Tee Khaw, Kudzai Nyamondo and Ketan Patel responding to this question. | | |
| | | | | | | At our brain tumour conference last September, neuro-oncologist Adrienne Boire spoke about her studies on how metastatic cancer cells adapt to inhabit the central nervous system.
Hear about some of the mechanisms these cancer cells deploy to outcompete neighbouring cells in extremely challenging microenvironments and how Adrienne’s research has been translated into the clinic for a phase 1 trial.
Join the conversation to find out more about future applications of cerebrospinal fluid liquid biopsies and the challenges of working at the intersection of neuroscience and oncology.
| | |
|
|---|
|
|
|
|
Final speaker announced at our children’s and young people’s cancers webinar |
| John Moppett, from University Hospitals Bristol and Weston NHS Foundation Trust, will be joining our upcoming webinar.
As a Consultant Paediatric Haematologist specialising in acute lymphoblastic leukaemia, John is actively involved in leading early- and late-phase clinical trials at local, national, and international levels. He is also the UK lead for the ALLTogether-1 trial.
Sign up to hear from John and the other expert speakers on 12 February, from 3 – 4:30pm (GMT). |
| | |
|
|
|
Raise the profile of your research: submit a nomination for the Innovation and Entrepreneurship Awards 2025 |
| The Cancer Research Horizons Innovation and Entrepreneurship Awards celebrate researchers at any stage of their entrepreneurial journeys, from early-career to established entrepreneurs, including those working in frontier technologies. The awards are a great opportunity for researchers to take their projects to the next level. Is that you, or someone who inspires you?
You can submit a nomination for yourself or a colleague, for one or more categories. Winners will receive up to £15,000 to boost their research, plus access to a network of like-minded entrepreneurs and industry connections, including investors.
Not a translational researcher, but know someone who may be interested? Forward this email to them.
The deadline for submissions is 17 March. |
| | |
|
|
|
| | Together we are
beating cancer |
| | |
|---|
|
|
|
| | | You are playing a crucial role in helping us beat cancer, so we'd like to continue to keep you updated on what we're up to. You can manage your preferences and unsubscribe here.
Your details are safe with us. Check out our Privacy Policy.
Our supporters are at the heart of everything we achieve at Cancer Research UK. Read our Fundraising Promise.
This email is from Cancer Research UK. Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ. |
|
|
|
